Browsing "School of Medicine" by Author Rabusa, C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 12 to 17 of 17 < previous 
PreviewIssue DateTitleAuthor(s)
2014Measures of disease status in systemic sclerosis: systematic reviewTien, T.; Ferdowsi, N.; Stevens, W.; Hudson, M.; Baron, M.; Rabusa, C.; Prior, D.; Proudman, S.; Nikpour, M.; 2014 ACR/ARHP Annual Meeting (14 Nov 2014 - 19 Nov 2014 : Boston, MA)
2016Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort studyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J.
2016Risk factors for development of pulmonary arterial hypertension in Australian scleroderma patientsMorrisroe, K.; Huq, M.; Stevens, W.; Rabusa, C.; Proudman, S.; Nikpour, M.; Annual European Congress of Rheumatology (EULAR 2016) (8 Jun 2016 - 11 Jun 2016 : London)
2016Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort studyMorrisroe, K.; Huq, M.; Stevens, W.; Rabusa, C.; Proudman, S.; Nikpour, M.; The Australian Scleroderma Interest Group (ASIG),
2016The association of low complement with disease activity in systemic sclerosis: a prospective cohort studyEsposito, J.; Brown, Z.; Stevens, W.; Sahhar, J.; Rabusa, C.; Zochling, J.; Roddy, J.; Walker, J.; Proudman, S.; Nikpour, M.
2016The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyThakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Sahhar, J.; G Walker, J.; Roddy, J.; Lester, S.; Rischmueller, M.; Zochling, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.M.; Nikpour, M.